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Abstract
Background: It has been observed that low-frequency stimulation (LFS) may be effective for dystonia, and the use of LFS may alleviate the need for frequent
battery changes in a subset of patients. The aim of this study was to analyze LFS as a strategy to treat deep brain stimulation (DBS) patients with various dystonias.
Methods: Subjects had to receive a minimum of 6 months of clinical follow-up at the University of Florida, and were required to have a minimum of 3 months on
a LFS trial. Twenty-seven dystonia DBS patients were retrospectively analyzed from the UF-INFORM database.
Results: Thirteen subjects met inclusion criteria. Of the 13 subjects, all had bilateral internal pallidum (GPi) DBS, and five (38.5%) remained with at least one side
on LFS settings at their last follow up (average follow up 24 months, range 6–46 months). Within the first 6 months, six (46%) subjects remained on LFS and seven
(54%) were changed to high-frequency stimulation (HFS). Those who remained on LFS settings at 6 months were characterized by shorter disease durations than
those on HFS settings. There were no significant differences in dystonia severity (Unified Dystonia Rating Scale and Burke–Fahn–Marsden Dystonia Rating Scale)
at baseline between the two settings. The estimated battery life for LFS (79.9¡30.5) was significantly longer than for HFS settings (32.2¡13.1, p,0.001)
Discussion: LFS was ultimately chosen for 38.5% of all subjects. Although this study failed to yield solid predictive features, subjects on LFS tended to have shorter
disease durations.
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Introduction
Dystonia is a complex neurological syndrome characterized by
repetitive, involuntary muscle co-contractions. The syndrome can be
classified by the pattern of distribution (focal, segmental, multifocal or
generalized), the etiology (primary or secondary), or the age of onset of
symptoms (early vs. late).1 Medical treatment for generalized dystonia
can be challenging, and in many cases disappointing. In recent years,
bilateral globus pallidus internus (GPi) deep brain stimulation (DBS)
surgery has emerged as a reasonable therapeutic modality for well-
selected and for well-screened cases of disabling, medication refractory
dystonia.1–6 Among the many advantages of DBS, flexibility in
programming has been one of the most attractive features, as this type
of flexibility may facilitate the achievement of a more tailored and
potentially better clinical response. The parameters on the DBS device
that can be adjusted by the clinician, including the active contacts (and
their array), the amplitude, the frequency, and the pulse width (PW) of
stimulation. There remains, however, little consensus regarding the
optimal parameters, and most DBS experts would argue that in
dystonia programming is highly empiric and patient specific.
Historically, programming for dystonia has been performed with
higher PWs (210 mseconds up to 450 mseconds), and higher frequencies
(130 Hz up to 185 Hz);1,3,6–9 however, recently lower PWs
(,210 mseconds) and lower frequencies (,100 Hz) have been
employed. There are currently few available data addressing high-
frequency stimulation (HFS) versus low-frequency stimulation (LFS)
clinical outcomes in dystonia. Also absent from most datasets are the
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many differing presentations of dystonia (e.g. focal, segmental,
generalized). Isaias et al.5 in a record review of 30 consecutive patients
with primary generalized dystonia (PGD) implanted with GPi DBS
reported that there was no difference in the overall clinical outcome of
HFS versus LFS DBS. The authors noted that shorter PWs and lower
frequencies had an added benefit for prolonged battery life. We
introduced a clinical protocol to enroll a consecutive group of mixed
dystonia patients (regardless of dystonia subtype), and to administer a
minimum of 3 months of LFS. Following this trial, if a less than
anticipated clinical outcome was achieved, patients were subsequently
converted to HFS in an attempt to improve their outcomes. The
patients were then followed and their outcomes and stimulation
settings recorded.
Methods
This study employed an Institutional Review Board (IRB) approved
database (UF-INFORM). Data were retrospectively obtained on the
general demographics (age, gender, type of dystonia, disease duration,
DYT-1 gene test results), stimulation parameters (voltage, rate, pulse
width) as well as the Unified Dystonia Rating Scale (UDRS) and
Burke–Fahn–Marsden Dystonia Rating Scale (BFM–DRS) motor
subscores when available. The maximal total score of the UDRS and
BFMDRS were 112 and 120 respectively.10 The scales were recorded
from 6 month and 12 month post-DBS follow-up visits, and they were
drawn from all available data. Subjects were started on LFS (defined as
a frequency of less than 100 Hz) and all outcomes were documented.
The analysis was designed to elucidate the characteristics that
potentially predicted who remained at LFS, and who converted to
HFS. Subjects had to receive a minimum of 6 months of clinical
follow-up at our institution (UF) to be included in the study, and they
must have received a minimum of a LFS trial for the first 3 months
after DBS surgery. The 3 month LFS trial was introduced in our DBS
programming clinic in 2004. Excluded from the cohort were patients
who had previous DBS surgery for dystonia at any outside institution,
the use of multiple DBS targets for dystonia, or the use of double leads
on a single target. Patients were also excluded if any programming
occurred outside of our institution, or if they did not complete a
minimum of 3 months of a LFS trial after DBS implantation.
All patients signed an informed consent and underwent DBS
surgery by the same neurosurgeon (KDF) and neurologist (MSO) team
at the University of Florida Center for Movement Disorders &
Neurorestoration between 2004 and 2009. The bilateral GPi DBS
procedure was staged for some subjects: one side followed by a second
hemispheric surgery 2–4 weeks later, or alternatively subjects had
bilateral surgery on the same day. All subjects underwent bilateral
quadripolar electrode (3387 Medtronic, Minneapolis) implants.
Implantable pulse generators (IPGs) were placed in another procedure,
under general anesthesia, and 1 month following the second DBS lead
surgery. Patients were seen 1 week after IPG placement for screening
of benefits and side effects at each of the four DBS lead contacts. A
monopolar configuration, with a set PW of 90 mseconds and a set
frequency of 135 Hz was utilized for these trials. Side effects were
monitored by increasing the stimulation amplitude until the patient
developed sensory, motor or visual phenomena. After checking
thresholds and confirming lead placement by a post-operative
magnetic resonance imaging–computed tomography (MRI–CT)
fusion study, each patient underwent subsequent programming
utilizing LFS over 3 months, pushing the voltage toward maximally
tolerated thresholds at each visit if clinical improvement was not
evidenced, or improvement was judged suboptimal. Programmers
were permitted to add cathodes (more active contacts) if there was a
lack of response, or a less than anticipated clinical improvement. The
estimates of battery life were obtained by calling Medtronic technical
support and by using the programming parameters at the last clinical
follow-up visit. All data were retrospectively collected from the UF-
INFORM database, and then used to compare LFS and HFS. The
Mann–Whitney test was utilized for continuous data because of the
small sample size, and because the data were not normally distributed.
The chi-square test was utilized for categorical data.
Results
A total of 27 dystonia subjects were identified in the database as
potentially being eligible for the study. These subjects were operated
between 2004 and 2009. From the 27 database records, 14 subjects
(seven male and seven female, mean age 20.9¡16.6, median age 12.5,
range 7–55 years) were excluded from further analysis because they
failed to meet the inclusion criteria. Ultimately 13 subjects (10 male
and three female, mean age 25.5¡19.8, median age 27.0 and range
0–62 years) were included. There were no statistical differences
between the included and excluded groups in terms age (Mann–
Whitney test, p50.627) and sex (chi-square, p50.248). The reasons for
exclusions were as follows: multiple targets (n52; one with GPi and
Vim and the other with GPi and Subthalamic Nucleua (STN) targets),
STN surgery for mitochondrial disease (n51; not a GPi target), double
leads placed on single GPi target (n52), DBS surgery at an outside
institution (n51), surgery prior to the year 2004 when the LFS
protocol was instituted (n53), failed to meet the minimum 3-month
period of LFS prior to converting to HFS (n52), DBS programming
performed outside of our institution (n51), no follow-up at our
institution for the first 6 months after DBS surgery (n51), and
initiation of HFS after infection and replacement of the subject’s
hardware 1 month post-DBS (n51).
General characteristics, dystonia patterns and DYT-1 status
Of the 13 subjects who qualified for analysis of outcomes, 10
subjects were male and three were female. One of these subjects had a
left GPi DBS lead revision 27 months post-operatively because of a
fracture; however, he met all inclusion criteria. The baseline and 6-
month post-DBS programming parameters were obtained prior to the
lead fracture and his last clinical follow-up was obtained after his lead
replacement. The disease characteristics of the subjects are summar-
ized in Table 1.
The mean age of symptom onset was 25.5 years (range 0–62 years).
Most of the subjects had generalized dystonia (n57). The other clinical
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dystonia patterns included: focal (cervical) dystonia (n54), segmental
(cervical and larynx, n51), and craniofacial (n51). Two subjects had
secondary dystonia: one subject had generalized dystonia secondary to
cerebral palsy, and the second subject had generalized tardive dystonia
secondary to neuroleptic exposure for a psychiatric condition. Of the
cohort, 11 had a primary dystonia, and of the primary dystonias, three
had documented DYT-1 gene mutations. There were two subjects
who were DYT-1 gene mutation negative, and the remaining eight
subjects in the cohort did not have documented genetic testing. Two
subjects had a fixed skeletal deformity (FSD), and, of these, one had a
primary dystonia and the other had a secondary dystonia. Baseline
UDRS scores were not available for all subjects (not available, n51).
Using the available scores the mean UDRS at baseline was 38.3 (range
7–82). Baseline BFM–DRS motor subscores were not available for all
subjects (not available, n54), but from those available the baseline
motor mean score was 42.2 (range 6–116), see Table 1.
Initial programming settings
All of the 13 subjects were initiated on a low frequency of 60 Hz on
both DBS leads (see Table 2). Initially, the PWs ranged from 150 to
210 mseconds, with amplitudes ranging from 2 to 3.5 V. Most of the
subjects were programmed with a monopolar configuration (n512)
using contacts 1 or 2 (leads numbered 0–3, with 0 representing the
ventral contact). There was one subject (subject #6) who was initially
programmed on a bipolar configuration for the right lead, and another
subject (subject #10) who had a double monopolar configuration on
the left lead.
Six months post-DBS follow up
After 6 months of chronic stimulation, six subjects (46%) remained
on LFS. The clinical pattern of dystonia distribution for those who
remained at LFS 6 months post DBS was generalized in four subjects
(66%), focal (cervical) dystonia (16%) in one subject, and segmental
(craniofacial) dystonia (16%) in one subject. One of the subjects had
HFS settings on the left lead and a LFS setting on the right lead, and
this subject was included because at least one lead was at LFS. All six
subjects were male. Dystonia was primary in all but one of the subjects.
The DYT-1 status in the primary dystonia subjects in the cohort
revealed two subjects who were gene mutation positive (33%), one
subject was gene mutation negative (33%), and two subjects did not
have genetic testing. The secondary dystonia subject was a tardive
dystonia case that resulted from neuroleptic exposure for treatment of
a psychiatric condition.
Seven subjects (n554%) were changed from LFS to HFS within the
first 6 months. The clinical pattern of dystonia distribution in this
group was as follows: generalized (n53, 43%), focal (cervical) (n53,
Table 1. Demographics of patients who had minimum of 3 months of low-frequency stimulation



















1 F 29 35 N/A YES 1 Cervical + larynx 7 N/A
2 M 8 31 pos NO 1 Gen 44 31
3 M birth 34 N/A NO 2 (CP) Gen 69 64.5
4 M 39 43 N/A NO 2 (TD) Gen 82 72
5 M 48 62 N/A NO 1 Cervical 12 8
6 F 51 73 N/A NO 1 Cervical 8 8
7 M 15 35 neg NO 1 Gen N/A N/A
8 M 62 67 N/A NO 1 Craniofacial 29 N/A
9 M 6 8 pos NO 1 Gen 71 N/A
10 F 29 60 N/A YES 1 Cervical 12 6
11 M 27 34 N/A NO 1 Cervical 8 8
12 M 5 11 pos NO 1 Gen 55 116
13 M 13 33 neg NO 1 Gen 63 66.5
UDRS, Unified Dystonia Rating Scale; N/A, not available; pos, positive; neg, negative; Gen, generalized dystonia; CP, cerebral palsy; TD, tardive dystonia; BFM–DRS M,
Burke–Fahn–Marsden Dystonia Rating Scale Motor subscore.
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Table 2. Programming settings at baseline and at the last follow-up for the deep brain simulation (DBS) leads.
Subject
#
Baseline parameters Parameters 6 months Parameters at last follow-up
Contacts Amp PW Freq Contacts Amp PW Freq Months1 Contacts Amp PW Freq EBL
1 R 1- 2.2 180 60 1- 3 180 135 28 1- 2.3 180 135 46
L 1- 2.2 180 60 1- 3.1 180 135 28 1- 2.3 180 60 89
2 R 5- 2.8 180 60 5- 1.7 180 135 42 5- 1.8 180 135 393
L 2- 3.3 180 60 2- 2.4 180 135 41 2- 2.5 180 135 393
32 R 1- 2.1 210 60 2- 2 450 185 13 1-/2- 3.0 120 5 .1203
L 2- 2.1 210 60 1-/2+ 2 450 185 13 1-/2- 2.0 120 5 .1203
4 R 6- 3.0 180 60 5-/6- 2.1 180 60 35 5-/6- 3.1 180 185 213
L 1- 3.0 180 60 1-/2+ 3 450 185 9 1-/2+ 3.0 450 185 213
5 R 2- 2.2 150 60 1-/2+ 3 150 135 6 1-/2+ 3.0 150 135 45
L 2- 2.2 150 60 1-/2+ 2.6 150 135 7 1-/2+ 2.6 150 135 54
6 R 1-/2+ 2.0 180 60 1-/2+ 2.3 210 185 12 1-/2+ 3.0 330 185 20
L 2- 2.3 180 60 1- 2.5 210 185 12 0-/1+ 3.5 330 185 16
7 R 1- 2.5 180 60 0-/1+ 2.2 150 135 27 1- 3.0 180 60 72
L 1- 2.5 180 60 0-/2+ 3 150 135 27 1- 3.1 180 60 70
8 R 5- 3.5 180 60 5-/6- 3.2 60 10 6 5-/6- 3.2 60 10 .1203
L 1- 3.4 180 60 1-/2+ 3.2 60 10 6 1-/2- 3.2 60 10 .1203
9 R 2- 2.6 180 60 2- 3.2 180 60 46 1-/2- 3.6 180 90 40
L 1- 2.8 180 60 1- 3 180 60 46 1-/2- 3.6 180 60 68
10 R 1- 2.0 180 60 1-/2-/3+ 2.3 450 135 39 1-/2-/3+ 3.3 330 145 25
L 0-/1- 2.0 180 60 1-/2-/3+ 4.5 450 135 38 1- 3.1 330 185 17
11 R 2- 2.5 180 60 2- 3.2 180 60 24 2- 3.5 180 60 58
L 2- 2.5 180 60 2- 3.2 180 60 24 2- 3.5 180 60 52
12 R 2- 2.1 150 60 2- 2.8 180 60 25 0-/2+ 2.3 210 80 44
L 1- 2.0 150 60 1- 2.8 180 60 25 1-/2- 2.3 180 80 66
13 R 2- 2.2 180 60 2- 3.2 180 80 23 2- 3.0 210 160 30
L 2- 2.2 180 60 2- 3.2 180 80 23 2- 3.5 180 100 46
DBS contacts are monopolar unless noted with a positive contact which indicates bipolar configuration.
1Months after placement of DBS lead at their last follow up.
2Subject 3 had failure of DBS and all hardware was removed 13 months post DBS, at last follow up devices were turned off. EBL: estimated battery life using
programming parameters at last clinical follow up.
3Kinetra IPGs, otherwise subjects had Soletra IPGs.
Abbreviations: Amp, amplitude of stimulation in volts; PW, pulse width; Freq, frequency of stimulation.
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43%), and segmental craniofacial (n51, 14%). Three subjects were
female (43%) and four were male (57%). The etiology for dystonia was
secondary in one subject (cerebral palsy), and primary in the other six
subjects. In the primary group, one subject was DYT-1 gene mutation
positive, one was negative, and four did not have documented genetic
testing.
There were no differences in age between the LFS group
(25.3¡22.2, median 20) and the HFS group (mean 25.7¡19.4,
median 29, Mann–Whitney test, p50.775). Disease duration was
significantly shorter in the LFS cohort (mean 7.3¡6.4, median 5.5)
versus the HFS cohort (mean 21.4¡9.6, median 22, Mann–Whitney
test, p50.015). Also there were no significant differences between two
groups in BFM-DRS score at baseline (LFS; mean 65.6¡44.3, median
69.25, HFS; mean 23.5¡25.1, median 8, Mann–Whitney test,
p5.081) and at 6 months (LFS; mean 35.1¡19.4, median 32.25,
HFS; mean 35.4¡19.6, median 26.5, Mann-Whitney test, p5.592).
There were no significant differences between the LFS group and HFS
group in UDRS score at baseline (LFS; mean 52.0¡28.1, median 61,
HFS; mean 25.3¡25.5, median 12, Mann–Whitney test, p50.127)
and at 6 months (LFS; mean 37.7¡19.5, median 38.5, HFS; mean
28.6¡22.3, median 23, Mann–Whitney test, p50.352). None of the
subjects in the LFS group had any fixed skeletal deformities (FSD).
Two subjects in the HFS cohort had FSDs.
Last clinical follow-up
Subjects were followed for an average of 24.0¡13.1 months (range
6–43 months) post DBS. A total of six out of 13 subjects (46.1%)
remained on LFS settings at their last clinical follow up. It is
noteworthy, that one of the subjects (patient #3) was at a very LFS
setting (vLFS) of 5 Hz, and had his devices turned off at the last clinical
follow-up. His hardware was removed because of lack of clinical
efficacy 13 months after DBS placement. This subject had a secondary
dystonia due to cerebral palsy. Examination of the subjects who were
at LFS at their last clinical follow-up revealed they were all male.
Subjects that were maintained on LFS settings at their last clinical
follow-up were not all identical subjects that were on LFS 6 months
post DBS. Two of the subjects who remained on LFS settings 6 months
post DBS were subsequently converted to HFS. Both of these subjects
had generalized dystonia without fixed skeletal deformities, and both
were male. One had a primary dystonia (DYT-1 mutation negative),
and the other had secondary dystonia. Furthermore, one subject who
had been changed to HFS at 6 months post DBS was later changed
back to LFS at the last clinical follow-up, and it was unclear whether
one state was superior to the other. There was no significant difference
in age (LFS; mean 20.6¡21.4, median 15, HFS; mean 31.3¡17.9,
median 34, Mann–Whitney test, p50.224) or in follow-up duration
(LFS; mean 23.9¡14.4, median 23, HFS; mean 24.1¡12.1, median
25, Mann–Whitney test, p50.718) between the LFS group and the
HFS group. Furthermore, there was no significant difference in disease
duration between the LFS group (mean 11.4¡11.5, median 6) and the
HFS group (19.0¡9.1, 21, Mann–Whitney test, p5.223).
Additionally, there were no significant differences between two groups
in UDRS baseline (LFS; mean 39.8¡29.2, median 42, HFS; mean
37.5¡31.8, median 28, Mann–Whitney test, p50.936) and at 12-
month post-DBS visit (LFS; mean 33.0¡23.8, median 33, HFS; mean
31.5¡24.6, median 31.5, Mann–Whitney test, p50.915). Also there
were no significant differences between the two groups in BFM-DRS
at baseline (LFS; mean 62.8¡54.0, median 64.5, HFS; mean
31.9¡30.4, median 19.5, Mann–Whitney test, p50.431) and at the
12-month post-DBS visit (LFS; mean 32.6¡23.6, median 32.5, HFS;
mean 39.0¡35.9, median 35, Mann–Whitney test, p50.773).
Cohort of subjects at LFS at 6 months and at the last clinical
follow-up
There were 4 (30.8%) subjects who remained with at least one side
on LFS settings 6 months post DBS, and who continued on LFS
settings at their last clinical follow up. All four were male and all four
had a primary dystonia (two were DYT-1 gene mutation positive). One
of the subjects had the right lead at HFS (100 Hz) and the left lead at
LFS (60 Hz), and this subject was therefore included in the LFS group.
The clinical pattern of distribution for these four subjects was
generalized (n52, 50%), focal (cervical) (n51, 25%), and segmental
(craniofacial) (n51, 25%). The average disease duration for this group
was 5 years, and ranged from 2 to 7 years. None of the subjects had a
FSD. The mean UDRS baseline score for this group was 40.75 (range
8–71), and the BFM-DRS motor subscore was not available for two of
the subjects.
Implantable pulse generator changes
There were four subjects that had dual channel IPGs (Kinetra), and
the remainder of the cohort had single channel IPGs (Soletra). There
were three subjects in the cohort who had an implantable pulse
generator (IPG) replaced at some point during the clinical follow-up,
and all were replaced as a result of the end of battery life. One of the
three subjects had two IPG-Soletra changes. The first IPG replace-
ment was performed 16 months post implant, and the second
replacement occurred at 20 months following this replacement. One
of the subjects had a single IPG-Soletra change on each side at 36
months post implant. The other subject had a single IPG change on
the right side at 25 months post implantation, and no changes of the
left IPG. Both subjects who had bilateral IPG changes were at HFS
parameters at 6 months post DBS. The one subject with a unilateral
IPG change remained at LFS at 6 months and also at the last clinical
follow-up.
Estimates of battery life were obtained for all the subjects in the
cohort using the parameters derived from the last clinical follow-up,
with the assumption that the devices were kept in the ‘‘On’’ state for 24
hours (see Table 2). The overall average battery life for the right
Soletra IPGs was 42.2 months (range 20–72 months) and for the left
side it was 53.1 months (range 16–89 months). The overall average
battery life for the Kinetra IPGs was 75 months (range 21–120
months). There were two subjects with a Kinetra that had an estimated
battery life of greater than 120 months, and this was felt to be due to
very-low-frequency settings (vLFS; 10 and 5 Hz). The Medtronic
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Technical Support system does not allow calculating estimates of
battery life if the frequency is less than 15 Hz, and this frequency had
to be used to calculate the estimate of battery life for these two subjects
as it was felt that it would not alter the final estimate. The estimated
battery life of the IPG (left or right) programmed for LFS (mean
79.9¡30.5, median 70) was significantly longer than the IPG
programmed for HFS (mean 32.2¡13.1, median 30, p,0.001).
Discussion
The results of this study revealed that up to 46% of dystonic patients
in a DBS clinic benefited from a trial with LFS. Further, 30.8% of
subjects in the cohort remained on LFS settings during the course of
their follow-up. The majority of subjects in the cohort were maintained
on HFS. The results from the study could be divided into three
categories: 1) those patients who remained on LFS during their clinical
follow up, 2) those who started on LFS and were subsequently changed
to HFS within the first 6 months of DBS programming, and 3) those
that were changed back to LFS at some point following their 6-month
visit. The study results revealed that the majority of the subjects in this
clinical cohort were changed to HFS within the first 6 months of
stimulation, and only four subjects (30.8%) ultimately remained on
LFS. There was not a clear predictive pattern that emerged for
subjects remaining on LFS. There was however a clinical trend for
subjects with shorter disease durations tending to be more likely to
remain on LFS settings. Interestingly, male subjects also had a more
promising response with LFS settings. DYT-1 status was recently
reported in the literature to be important in generalized dystonia
patients; however, in our small dataset, we could neither confirm nor
refute this relationship. Although there was a small sample size of three
DYT-1 subjects, one had to be changed to HFS within the first 6
months of stimulation initiation. There were not clear predictive
factors in clinical dystonia subtype and the response to LFS. The
majority of our cohort had a generalized distribution of dystonia
(n57), and of the generalized dystonia subjects (n52), 28.5% remained
on LFS. Although it was not statistically significant, the baseline BFM-
DRS and UDRS scores tended to be severe in the LFS group.
Interestingly, the one subject with craniofacial dystonia remained on a
LFS setting with a positive response. It is known that patients who have
FSDs may reveal a less robust response to DBS, and in our cohort, the
two subjects with FSDs both required HFS.
Recent observations in the literature have revealed that lower
frequencies of stimulation were equivalent to higher frequencies in
clinical outcomes for generalized dystonia, and our data in general
support comparable outcomes for both types of stimulation.2 In our
small cohort, all of our subjects were started on LFS and less than half
remained at LFS settings 6 months post DBS. Further, following 6
months of therapy there were more conversions to HFS.
Disease severity was diverse as highlighted by the subjects’ differing
baseline UDRS and BFM-DRS motor scores. In the group that was
maintained on LFS during clinical follow up, the baseline UDRS
scores ranged from 8 to 71, and the baseline BFM-DRS motor
subscores ranged from 8 to 116, suggesting that disease severity was
not a likely predictive factor of a favorable LFS outcome. Moreover, in
our cohort some focal and segmental dystonias seemed to benefit from
a trial of LFS.
It is reasonable to expect that HFS parameters will deplete the
battery more quickly in DBS. In our cohort, there were three subjects
who had IPG replacements as a result of end of battery life. Overall,
the group on HFS had a lower estimated battery life for both sides
than the LFS group. More frequent battery changes represent an
important clinical issue as battery changes increase the likelihood for
infections, are an inconvenience to the patients, and also increase cost.
Battery issues proved a definite advantage for the LFS group.
There were several limitations to our study. A prospective trial of
HFS vs. LFS will be needed to exclude the many possible biases of an
open case series. Other programming variables such as the active
stimulation contacts, the amplitude, and the pulse width of stimulation
were not considered in this series, and therefore these variables may
have affected the outcome. Additionally, although there has been a
recent review on programming approaches for dystonia DBS,11 no
standardized approach has been adopted across continents.
Programming for dystonia DBS can be tricky, as clinical improve-
ments are not usually manifested at the bedside. Another weakness was
that the statistical power for this study was low because of the small
sample size. Additionally, the small cohort was diverse in dystonia
subtypes, DYT-1 status, and disease duration. The majority of the
subjects in the case series did not have genetic testing for DYT-1, and
in a larger study this could proven to be an important outcome
predictor for LFS vs. HFS. Finally the variable and broad age range
could have influenced outcome.
In our clinical experience, LFS was effective for only a subset of
patients. The data on predictive factors was not conclusive. There was
a trend for subjects with shorter disease durations to remain on LFS
settings. Taking into careful consideration that there exists a group of
patients who may have a favorable clinical outcome with LFS, it is
reasonable to offer this option to dystonia patients, regardless of DYT-
1 status, dystonia distribution pattern, gender, disease severity, or age.
We suspect that underlying physiology may play an important role in
response to LFS versus HFS, and this question remains to be addressed
by future studies. LFS, if successful, has the advantage of consuming
less battery, being more cost effective, and having less surgical related
comorbidity.
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